Prokidney to participate in fireside chat at the morgan stanley global healthcare conference

Winston-salem, n.c., sept. 05, 2023 (globe newswire) -- prokidney corp. (nasdaq: prok) (“prokidney” or the “company”), a leading late clinical-stage cellular therapeutics company focused on preserving kidney function in patients suffering from chronic kidney disease (ckd), today announced that dr. tim bertram, chief executive officer, will participate in a fireside chat at the morgan stanley global healthcare conference, being held in new york, ny from september 11 – 14, 2023.
PROK Ratings Summary
PROK Quant Ranking